SCHEMBL887273

SCHEMBL887273

S=C1CCCCC1=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17686782 0.95
SCHEMBL941669 0.90
SCHEMBL3180245 0.79 ALDH1A1 (0.33)
SCHEMBL3188726 0.79 ALDH1A1 (0.33)
SCHEMBL3199147 0.79 ALDH1A1 (0.33)
SCHEMBL3198927 0.79 ALDH1A1 (0.33)
SCHEMBL3188728 0.79 ALDH1A1 (0.33)
SCHEMBL3188519 0.76 ALDH1A1 (0.32)
SCHEMBL3199010 0.76 ALDH1A1 (0.32)
SCHEMBL3182878 0.76 ALDH1A1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11318206-B2 Compounds and methods for trans-membrane delivery of molecules APOSENSE LTD (IL) 2022-05-03 US claimed
US-20180243426-A1 COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES APOSENSE LTD. (IL) 2018-08-30 US claimed
EP-3337515-A1 COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES Aposense Ltd. (IL) 2018-06-27 EP claimed
US-9889202-B2 Compounds and methods for trans-membrane delivery of molecules APOSENSE LTD. (IL) 2018-02-13 US claimed
US-20170100486-A1 COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES APOSENSE LTD. (IL) 2017-04-13 US claimed
US-20170080095-A1 COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES APOSENSE LTD. (IL) 2017-03-23 US claimed
WO-2017029664-A1 COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES APOSENSE LTD. (IL) 2017-02-23 WO claimed
US-20170037401-A1 COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES APOSENSE LTD. (IL) 2017-02-09 US claimed
US-20160129125-A1 COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES APOSENSE LTD. (IL) 2016-05-12 US claimed
US-20160120996-A1 COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES APOSENSE LTD. (IL) 2016-05-05 US claimed
US-20160106855-A1 COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES APOSENSE LTD. (IL) 2016-04-21 US claimed
EP-3337515-B1 COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES APOSENSE LTD (IL) 2024-03-13 EP disclosed
CN-110662746-B Compounds as orally administered prodrugs of beta-lactamase inhibitors, pharmaceutical compositions thereof and use for treating bacterial infections 阿里萨制药有限公司 2022-08-19 CN disclosed
US-11318206-B2 Compounds and methods for trans-membrane delivery of molecules APOSENSE LTD (IL) 2022-05-03 US disclosed
CN-113543812-A ADC with sulfhydryl multiple linker 西进公司 2021-10-22 CN disclosed
WO-2009105140-A2 METALLOENZYME INHIBITORS USING METAL BINDING MOIETIES IN COMBINATION WITH TARGETING MOIETIES VIAMET PHARMACEUTICALS, INC. (US) 2009-08-27 WO disclosed
US-20070142639-A1 Process for production of amines TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
US-20070142639-A1 Process for production of amines TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
EP-0644206-A1 Olefin polymerization catalyst and process for preparing polyolefin SHOWA DENKO KABUSHIKI KAISHA (JP) 1995-03-22 EP disclosed
US-3931126-A MODIFICATION OF CONJUGATED DIENE POLYMERS BY TREATMENT WITH ORGANOLITHIUM AND N,N,N',N'-TETRAMETHYLALKYLENEDIAMINE COMPOUNDS PHILLIPS PETROLEUM COMPANY (US) 1976-01-06 US disclosed